Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Gina Kruse MD, MS, MPH

Gina Kruse MD, MS, MPH

Associate Professor of Medicine; Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, Colorado

Dr. Kruse is a visiting Associate Professor in the Division of General Internal Medicine at the University of Colorado School of Medicine. She trained in internal medicine and primary care at Massachusetts General Hospital, completed a Harvard Medical School General Internal Medicine research fellowship, earned her MPH in Clinical Effectiveness from the Harvard T.H. Chan School of Public Health followed by a post-doctoral fellowship in Cancer Prevention from the Department of Social and Behavioral Sciences.

Dr. Kruse’s research examines interventions to improve the delivery of preventive services with a focus on improving tobacco cessation treatment in healthcare settings in the US and internationally.


Gina Kruse has a family financial interest in two privately held digital health companies Dimagi, Inc. and Cogito, Inc. She has received grant support from NIH and an award administered by the National Comprehensive Cancer Network with funding from Astra-Zeneca.